Clinical Trial Update: Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma [Phase 1]

View source ↗

Summary

This completed Phase 1 trial evaluated the combination of S-1 and sorafenib in patients with advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Samsung Medical Center | Conditions: Hepatocellular Carcinoma | Phase 1 | Status: COMPLETED